Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.79 -0.68 (-1.81%)
As of: Aug 20, 2026 · 3:57 PM EDT

Teva Pharmaceutical Industries (TEVA) Change in Working Capital (2025 - 2026)

Teva Pharmaceutical Industries' (TEVA) quarterly Change in Working Capital came in at -$164.0 million in Q2 2026, up 51.19% YoY from -$108.5 million in Q2 2025, and up 73.42% on a QoQ basis from -$617.0 million in Q1 2026.

Teva Pharmaceutical Industries (TEVA) Change in Working Capital (2025 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVA) has 2 years of Change in Working Capital data on file, last reported at -$164.0 million in Q2 2026.

  • Quarterly Change in Working Capital rose 51.19% year-over-year to -$164.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.8 billion (changed N/A YoY) and the FY2025 annual result came in at -$1.4 billion, down 214.02% from the prior year.
  • Change in Working Capital improved to -$164.0 million in Q2 2026, from -$617.0 million in the prior quarter.
  • In the past five years, Change in Working Capital ranged from a high of -$164.0 million in Q2 2026 to a low of -$700.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -164.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alkermes 8.02 Bn 7.37 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -164.00 Mn
Jun 30, 2026 -164.00 Mn
Mar 31, 2026 -617.00 Mn
Mar 31, 2026 -617.00 Mn
Jun 30, 2025 -336.00 Mn
Jun 30, 2025 -336.00 Mn
Mar 31, 2025 -700.00 Mn
Mar 31, 2025 -700.00 Mn